Cibc Private Wealth Group, LLC Arcutis Biotherapeutics, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 8,107 shares of ARQT stock, worth $200,729. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,107
Previous 7,782
4.18%
Holding current value
$200,729
Previous $108,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ARQT
# of Institutions
247Shares Held
132MCall Options Held
407KPut Options Held
216K-
Jennison Associates LLC12.3MShares$303 Million0.14% of portfolio
-
Suvretta Capital Management, LLC New York, NY11.5MShares$286 Million5.56% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$266 Million3.47% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA9.87MShares$244 Million7.3% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$213 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $1.49B
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...